Àڱ󻸷¾ÏÁ¾¿¡¼ bcl-2, p53, Ç÷°ü³»ÇǼºÀåÀÎÀÚÀÇ ¹ßÇö°ú ¹Ì¼¼Ç÷°ü¹Ðµµ
Microvessel Density and Expressions of bcl-2, p53, and Vascular Endothelial Growth Factor in Endometrial Carcinoma
±è¼ø¿µ, Á¤ÇØÁø, ¹Ú¸í¼±, Çã¹æ,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼ø¿µ ( Kim Soon-Young )
°í½Å´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Á¤ÇØÁø ( Jeong Hae-Jin )
¾ð¾çº¸¶÷º´¿ø Çغκ´¸®°ú
¹Ú¸í¼± ( Park Myeng-Sun )
°í½Å´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Çã¹æ ( Huh Bang )
°í½Å´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
KMID : 0357920010350050401
Abstract
Background: Recent studies have shown that oncogenes and tumor suppressor genes are involved in tumorigenesis and tumor progression. The inverse role of bcl-2 and p53 in endometrial carcinomas has been debated. Moreover, their roles in angiogenesis as well as the interrelationship between prognostic clinico-pathological factors and angiogenesis have not been elucidated in endometrial carcinomas.
Methods: The expression rates of bcl-2, p53 and vascular endothelial growth factor (VEGF) in thirty-eight cases of surgically removed endometrial carcinomas were investigated using an avidin-biotin complex method of immunohistochemistry. CD34 immunostain for microvessel density (MVD) was also performed.
Results: The expression rate of bcl-2 was higher in the endometrioid type carcinoma (43.8%) than in the non-endometriod type carcinoma (16.7%). There was a significantly increased bcl-2 expression in grade I compared to grades II and III (p<0.05). The p53 expression rate was significantly higher in the non-endometriod type carcinoma than in the endometrioid type carcinoma (p<0.05).The VEGF expression rate was higher in the non-endometriod type carcinoma (83.3%) than in the endometrioid carcinoma (28.1%). Differences of MVD according to stages, histological types, grades and bcl-2, p53 and VEGF expressions were not noted.
Conclusions: The expression rate of bcl-2 increases in the low grade endometrial carcinoma more than in the high grade one, so it may be suggested that bcl-2 expression could be used for an ancillary prognosticator. However, p53 and VEGF expressions and microvessel density may not have any prognostic value.
Å°¿öµå
Carcinoma;Endometrium;Genes;bcl-2;p53
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸